Skip to NavigationSkip to content

Pharmafile.com's weekly COVID-19 news round-up

Published on 12/08/20 at 09:30am
Photo by the CDC

The coronavirus news this week once again focuses on vaccines, as AstraZeneca signed its first deal in China to produce and deliver its vaccine candidate, while the US will pay Johnson and Johnson more than $1 billion to create 100 million doses of a vaccine. In terms of people being willing to take a vaccine, 35% of Americans say they have no plans to be inoculated against the virus, according to new polling.

In hydroxychloroquine news, researchers at the University of Oxford have said that the drug could be beneficial to COVID-19 patients, despite a general lack of evidence for its effectiveness. 

 1. AstraZeneca seals manufacturing deal to deliver COVID-19 vaccine in China - Published on 07/08/2020

AstraZeneca has signed its first deal in China to produce and deliver its vaccine candidate against COVID-19 in the country, partnering up with manufacturing firm Shenzhen Kangtai Biological Products.

2. Researchers at the University of Oxford have said hydroxychloroquine could still be a viable COVID-19 treatmentPublished on 07/08/2020

Researchers at the University of Oxford have said that hydroxychloroquine could be beneficial to COVID-19 patients, despite a general lack of evidence for its effectiveness. 

3. US to pay Johnson and Johnson $1 billion for COVID-19 vaccine - Published on 06/08/2020

The US will pay Johnson and Johnson more than $1 billion to create 100 million doses of COVID-19 vaccine.

4. Over a third of Americans say they won’t take a coronavirus vaccinePublished 10/08/2020

35% of Americans say they have no plans to take a COVID-19 vaccine, according to new polling.

5. Early promise from Novavax's vaccine candidate for COVID-19Published 07/08/2020

New Phase 1/2 on Novavax’s COVID-19 vaccine candidate NVX‑CoV2373 has shown that the therapy generated “robust antibody responses” when used with or without the company’s Matrix‑M adjuvant.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches